IDH2 and cancer: Moreover, the metabolic reprogramming generated by IDH mutation makes cancer cells extremely vulnerable to NAD depletion: indeed, a recent study by Cahill and colleagues showed that NAD deprivation leads to cancer regression in IDH-mutated GBM [271].